Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32737300.
- Also identified by DOI 10.1038/s41467-020-17696-2 and PMC identifier 7395761.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr Virus (EBV) establish life-long infections and are associated with malignancies. Striking geographic variation in incidence and the fact that virus alone is insufficient to cause disease, suggests other co-factors are involved. Here we present epidemiological analysis and genome-wide association study (GWAS) in 4365 individuals from an African population cohort, to assess the influence of host genetic and non-genetic factors on virus antibody responses. EBV/KSHV co-infection (OR = 5.71(1.58-7.12)), HIV positivity (OR = 2.22(1.32-3.73)) and living in a more rural area (OR = 1.38(1.01-1.89)) are strongly associated with immunogenicity. GWAS reveals associations with KSHV antibody response in the HLA-B/C region (p = 6.64 × 10<sup>-09</sup>). For EBV, associations are identified for VCA (rs71542439, p = 1.15 × 10<sup>-12</sup>). Human leucocyte antigen (HLA) and trans-ancestry fine-mapping substantiate that distinct variants in HLA-DQA1 (p = 5.24 × 10<sup>-44</sup>) are driving associations for EBNA-1 in Africa. This study highlights complex interactions between KSHV and EBV, in addition to distinct genetic architectures resulting in important differences in pathogenesis and transmission.
Medical subject headings
- Antibodies, Viral
- Disease Resistance
- Epstein-Barr Virus Infections
- Henipavirus Infections
- Host-Pathogen Interactions
- Sarcoma, Kaposi